NCT05628987

Brief Summary

This is a multicenter, case-control study that aims to investigate the relationship between microbiota and sperm quality via stool, blood, and urine microbiome, metabolomics, and collected clinical metadata. The results of the spermatogenic dysfunction, including aspermia, oligozoospermia, asthenozoospermia, and teratozoospermia, will be compared to normal basic semen analysis utilizing the World Health Organization (WHO) semen analysis procedure 5th edition.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
306

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2023

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 29, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

February 20, 2023

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

July 24, 2024

Status Verified

July 1, 2024

Enrollment Period

2.4 years

First QC Date

November 17, 2022

Last Update Submit

July 22, 2024

Conditions

Keywords

MicrobiotaInfertility, MaleSperm

Outcome Measures

Primary Outcomes (2)

  • Microbiome

    The microbial composition of the stool samples was determined by 16S rRNA (ribosomal ribonucleic acid) gene sequencing analysis and metagenomics. Comparison of microbial abundance and diversity of healthy volunteers and patients with spermatogenic dysfunction.

    Baseline

  • Metabolomics

    Metabolomics is the large-scale study of small molecules, such as fatty acids, bile acids, lipid mediators and others. Comparison of metabolites of healthy volunteers and patients with spermatogenic dysfunction.

    Baseline

Secondary Outcomes (17)

  • Physical activity time

    Baseline

  • Daily sitting time

    Baseline

  • Eating habits

    Baseline

  • Sleeping time

    Baseline

  • Education level

    Baseline

  • +12 more secondary outcomes

Study Arms (5)

Azoospermia

After an abstinence period of 2-7 days, two basic semen analysis, the absence of spermatozoa

Other: no intervention

Oligozoospermia

After an abstinence period of 2-7 days, the total sperm number \<39\*10\^6 per ejaculate or the sperm concentration \< 15 \* 10\^6 per ml

Other: no intervention

Asthenozoospermia

After an abstinence period of 2-7 days, the progressive motility (PR) \< 32%

Other: no intervention

Teratozoospermia

After an abstinence period of 2-7 days, the percentage of morphologically normal spermatozoa \<4%

Other: no intervention

Control

After an abstinence period of 2-7 days, the basic semen analysis is normal.

Other: no intervention

Interventions

Observational studies, no intervention

AsthenozoospermiaAzoospermiaControlOligozoospermiaTeratozoospermia

Eligibility Criteria

Age18 Years - 45 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Healthy volunteers and patients will be recruited from the outpatient clinics of the Department of Andrology, Reproduction in our participant hospitals. Patients are from licensed doctor of the clinical research center. The age of healthy volunteers and patients in the same hospital will be matched.

You may qualify if:

  • Aged 18 to 45 years, males
  • Body Mass Index (BMI):18.5-29.9 kg/m\^2
  • After an abstinence period of 2-7 days, two abnormal semen analysis, the absence of spermatozoa from both replicates will be included in the azoospermia group, the total sperm number (\<39\*10\^6 per ejaculate) or the sperm concentration ( \< 15 \* 10\^6 per ml) will be oligozoospermia group, the progressive motility (PR) (\< 32%) will be asthenozoospermia group; the percentage of morphologically normal spermatozoa (\<4%) will be teratozoospermia group
  • Willing to provide feces, urine, blood samples, able to complete study questionnaires aimed at lifestyle factors (cigarette smoking, high temperature environment and others ) and other data collection instruments (e.g. physical activity, food frequency questionnaire, stress and others)

You may not qualify if:

  • Age \< 18 or \> 45 years
  • History of Zocanidin, Vitamin E, antibiotics, clyster, gastrointestinal endoscope in the past 30 days, or other drugs known to interact with semen quality or gut microbiota, history of high alcohol consumption (liquor over 200 ml, beer over 1000 ml) in the past 7 days or drinking every week in the past month
  • A known genetic cause of male factor spermatogenesis dysfunction, including chromosomal or gene disorders (e.g. Y chromosome deletions, CFTR mutation)
  • History of male reproductive system (e.g. testis, epididymis, seminiferous duct and others) damage, surgery, tumor or infection
  • History of Crohn's disease, ulcerative colitis, acute gastrointestinal disease, renal failure, liver cirrhosis, hypoplasia, X-rays exposure and other diseases related to spermatogenic dysfunction, history of intestinal gastrointestinal surgery (exclude appendix surgery)
  • History of psychoses or other mental conditions that would result in cognitive impairment and inability to participate in any part of this study including the informed consent process

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Guangdong Provincial Fertility Hospital

Guangzhou, Guangdong, 510000, China

NOT YET RECRUITING

Guangdong Second Provincial General Hospital

Guangzhou, Guangdong, 510000, China

NOT YET RECRUITING

Zhujiang Hospital of Southern Medical University

Guanzhou, Guangdong, 510280, China

RECRUITING

Related Publications (4)

  • He Y, Wu W, Zheng HM, Li P, McDonald D, Sheng HF, Chen MX, Chen ZH, Ji GY, Zheng ZD, Mujagond P, Chen XJ, Rong ZH, Chen P, Lyu LY, Wang X, Wu CB, Yu N, Xu YJ, Yin J, Raes J, Knight R, Ma WJ, Zhou HW. Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nat Med. 2018 Oct;24(10):1532-1535. doi: 10.1038/s41591-018-0164-x. Epub 2018 Aug 27.

    PMID: 30150716BACKGROUND
  • Yang H, Zhang J, Xue Z, Zhao C, Lei L, Wen Y, Dong Y, Yang J, Zhang L. Potential Pathogenic Bacteria in Seminal Microbiota of Patients with Different Types of Dysspermatism. Sci Rep. 2020 Apr 23;10(1):6876. doi: 10.1038/s41598-020-63787-x.

    PMID: 32327694BACKGROUND
  • Ding N, Zhang X, Zhang XD, Jing J, Liu SS, Mu YP, Peng LL, Yan YJ, Xiao GM, Bi XY, Chen H, Li FH, Yao B, Zhao AZ. Impairment of spermatogenesis and sperm motility by the high-fat diet-induced dysbiosis of gut microbes. Gut. 2020 Sep;69(9):1608-1619. doi: 10.1136/gutjnl-2019-319127. Epub 2020 Jan 2.

    PMID: 31900292BACKGROUND
  • Martinot E, Thirouard L, Holota H, Monrose M, Garcia M, Beaudoin C, Volle DH. Intestinal microbiota defines the GUT-TESTIS axis. Gut. 2022 Apr;71(4):844-845. doi: 10.1136/gutjnl-2021-324690. Epub 2021 May 13. No abstract available.

    PMID: 33985968BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Feces, urine, blood

MeSH Terms

Conditions

Infertility, MaleAzoospermiaOligospermiaAsthenozoospermiaTeratozoospermia

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesInfertilityMale Urogenital Diseases

Study Officials

  • Hongwei Zhou

    Southern Medical University, China

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 17, 2022

First Posted

November 29, 2022

Study Start

February 20, 2023

Primary Completion

June 30, 2025

Study Completion

June 30, 2025

Last Updated

July 24, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations